FemTech Founder: An Interview with Selectivity CEO, Jonathan Gubspun
Jonathan Gubspun is the CEO of Selectivity, a fertility company producing at-home sperm selection and intrauterine insemination devices.
As part of our FemTech Founder series, FemTech.Live interviewed Jonathan about their mission to make fertility accessible for all.
United Health Foundation Launches Partnership to Improve Maternal Health
The United Health Foundation, the philanthropic foundation of UnitedHealth Group (NYSE: UNH), is partnering with Touro University Nevada…
Mums Use Their Influence to Raise Awareness for Maternal Mental Health Awareness Week
This week (3-9 May) is Maternal Mental Health Awareness Week, and mums are getting together to raise awareness…
Why the Fertility Market is Ripe for Disruption
The global fertility and pregnancy rapid test kits market is estimated to be valued at $12 million in terms of…
Mirvie Developing First Early Detection RNA Test for Pregnancy Complications
Mirvie, a pioneer in pregnancy health, today announced it is making rapid progress toward developing a simple, personalised…
CrazyCap Named a Winner in Women’s Health 2021 Fit Tech Awards
Women’s Health Magazine has announced the winners of its 2021 Fit Tech Awards, and CrazyCap was selected as…
Priya® Fertility Sensor Study to be Presented at ACOG Annual Meeting
A study determining the efficacy of the Priya® Fertility System ovulation prediction compared to traditional ovulation prediction methods will be…
Ruby Love Secures Investment, Led by SteelSky Ventures
Ruby Love, a Long Island, New York-based period apparel company, has recently closed a round of funding led by the…
A New Definition for Menstrual Health
A collaboration of experts, including Dr Julie Hennegan, has developed a definition of menstrual health to provide clarity, a…
OCON’s IUB™ Ballerine® Awarded by Frost & Sullivan
Based on its recent analysis of the global intrauterine device (IUD) market, Frost & Sullivan recognizes OCON Healthcare (OCON) with the 2021…